Athira Pharma Statistics

Total Valuation

Athira Pharma has a market cap or net worth of $10.54 million. The enterprise value is -$25.01 million.

Market Cap	10.54M
Enterprise Value	-25.01M

Important Dates

The last earnings date was Friday, May 9, 2025, after market close.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Athira Pharma has 39.04 million shares outstanding. The number of shares has increased by 1.42% in one year.

Current Share Class	39.04M
Shares Outstanding	39.04M
Shares Change (YoY)	+1.42%
Shares Change (QoQ)	+0.88%
Owned by Insiders (%)	13.57%
Owned by Institutions (%)	20.85%
Float	25.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.28
P/TBV Ratio	0.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.26, with a Debt / Equity ratio of 0.03.

Current Ratio	7.26
Quick Ratio	6.68
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -110.70% and return on invested capital (ROIC) is -67.00%.

Return on Equity (ROE)	-110.70%
Return on Assets (ROA)	-55.53%
Return on Invested Capital (ROIC)	-67.00%
Return on Capital Employed (ROCE)	-206.79%
Revenue Per Employee	n/a
Profits Per Employee	-$3.07M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.26% in the last 52 weeks. The beta is 3.04, so Athira Pharma's price volatility has been higher than the market average.

Beta (5Y)	3.04
52-Week Price Change	-87.26%
50-Day Moving Average	0.29
200-Day Moving Average	0.84
Relative Strength Index (RSI)	47.92
Average Volume (20 Days)	198,352

Short Selling Information

The latest short interest is 855,096, so 2.19% of the outstanding shares have been sold short.

Short Interest	855,096
Short Previous Month	826,618
Short % of Shares Out	2.19%
Short % of Float	3.40%
Short Ratio (days to cover)	4.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-78.62M
Pretax Income	-113.45M
Net Income	-79.75M
EBITDA	-77.65M
EBIT	-78.62M
Earnings Per Share (EPS)	-$2.06

Full Income Statement

Balance Sheet

The company has $36.67 million in cash and $1.12 million in debt, giving a net cash position of $35.55 million or $0.91 per share.

Cash & Cash Equivalents	36.67M
Total Debt	1.12M
Net Cash	35.55M
Net Cash Per Share	$0.91
Equity (Book Value)	37.33M
Book Value Per Share	0.96
Working Capital	34.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.03 million and capital expenditures -$28,000, giving a free cash flow of -$86.06 million.

Operating Cash Flow	-86.03M
Capital Expenditures	-28,000
Free Cash Flow	-86.06M
FCF Per Share	-$2.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Athira Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.42%
Shareholder Yield	-1.42%
Earnings Yield	-756.50%
FCF Yield	-816.39%

Analyst Forecast

The average price target for Athira Pharma is $11.25, which is 4,066.67% higher than the current price. The consensus rating is "Buy".

Price Target	$11.25
Price Target Difference	4,066.67%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1